These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27017007)

  • 1. Engineering Human Microbiota: Influencing Cellular and Community Dynamics for Therapeutic Applications.
    Woloszynek S; Pastor S; Mell JC; Nandi N; Sokhansanj B; Rosen GL
    Int Rev Cell Mol Biol; 2016; 324():67-124. PubMed ID: 27017007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characterization, influence and manipulation of the gastrointestinal microbiota in health and disease].
    García-Mazcorro JF; Garza-González E; Marroquín-Cardona AG; Tamayo JL
    Gastroenterol Hepatol; 2015; 38(7):445-66. PubMed ID: 25769877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbiota abnormalities in inflammatory airway diseases - Potential for therapy.
    Gollwitzer ES; Marsland BJ
    Pharmacol Ther; 2014 Jan; 141(1):32-9. PubMed ID: 23969226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent progress in engineering human-associated microbiomes.
    Yaung SJ; Church GM; Wang HH
    Methods Mol Biol; 2014; 1151():3-25. PubMed ID: 24838875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterisation and therapeutic manipulation of the gut microbiome in inflammatory bowel disease.
    Schulberg J; De Cruz P
    Intern Med J; 2016 Mar; 46(3):266-73. PubMed ID: 26968595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Physiological patterns of intestinal microbiota. The role of dysbacteriosis in obesity, insulin resistance, diabetes and metabolic syndrome].
    Halmos T; Suba I
    Orv Hetil; 2016 Jan; 157(1):13-22. PubMed ID: 26708682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The involvement of gut microbiota in inflammatory bowel disease pathogenesis: potential for therapy.
    Cammarota G; Ianiro G; Cianci R; Bibbò S; Gasbarrini A; Currò D
    Pharmacol Ther; 2015 May; 149():191-212. PubMed ID: 25561343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microbiome in early life: self-completion and microbiota protection as health priorities.
    Dietert RR
    Birth Defects Res B Dev Reprod Toxicol; 2014 Aug; 101(4):333-40. PubMed ID: 25044451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Approaches for In Situ Gut Microbiome Manipulation.
    Lee HL; Shen H; Hwang IY; Ling H; Yew WS; Lee YS; Chang MW
    Genes (Basel); 2018 Jul; 9(7):. PubMed ID: 30002345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbiome Disturbances and Autism Spectrum Disorders.
    Rosenfeld CS
    Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manipulating Bacterial Communities by in situ Microbiome Engineering.
    Sheth RU; Cabral V; Chen SP; Wang HH
    Trends Genet; 2016 Apr; 32(4):189-200. PubMed ID: 26916078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The developing intestinal microbiome: probiotics and prebiotics.
    Neu J
    World Rev Nutr Diet; 2014; 110():167-76. PubMed ID: 24751628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can inflammatory bowel disease be permanently treated with short-term interventions on the microbiome?
    Berg D; Clemente JC; Colombel JF
    Expert Rev Gastroenterol Hepatol; 2015 Jun; 9(6):781-95. PubMed ID: 25665875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiota in Inflammatory Bowel Disease Pathogenesis and Therapy: Is It All About Diet?
    Serban DE
    Nutr Clin Pract; 2015 Dec; 30(6):760-79. PubMed ID: 26452390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Gut Microbiota-Brain Axis by Probiotics, Prebiotics, and Diet.
    Liu X; Cao S; Zhang X
    J Agric Food Chem; 2015 Sep; 63(36):7885-95. PubMed ID: 26306709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microbiome engineering: Current applications and its future.
    Foo JL; Ling H; Lee YS; Chang MW
    Biotechnol J; 2017 Mar; 12(3):. PubMed ID: 28133942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiome-based therapeutics: Opportunity and challenges.
    Pant A; Das B
    Prog Mol Biol Transl Sci; 2022; 191(1):229-262. PubMed ID: 36270680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Designing microbial consortia with defined social interactions.
    Kong W; Meldgin DR; Collins JJ; Lu T
    Nat Chem Biol; 2018 Aug; 14(8):821-829. PubMed ID: 29942078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The microbiome: current and future view of an ancient paradigm.
    Neish AS; Pacifici R; Mulle JG; Kraft CS; Stephens DS
    Future Microbiol; 2017 Aug; 12():831-834. PubMed ID: 28660775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.